#COVID-19 FACTS
- Nov 19, 2020
- 1 min read
PFIZER AND BIONTECH CONCLUDE PHASE 3 STUDY OF COVID-19 VACCINE CANDIDATE, MEETING ALL PRIMARY EFFICACY ENDPOINTS
Source: https://bit.ly/3pEQGCJ
top of page
OVER PANDEMIC CHAOS
Search
![[COVID-19] 11.18.2020 COUNT](https://static.wixstatic.com/media/1e97e3_d9ee5fd499034d518629de22ddf2590f~mv2.png/v1/fill/w_940,h_788,al_c,q_90,enc_avif,quality_auto/1e97e3_d9ee5fd499034d518629de22ddf2590f~mv2.png)
![COVID-19 FACTS [MODERNA VACCINE]](https://static.wixstatic.com/media/1e97e3_a970aa90bd0b4a91a4c4241afc6dc41c~mv2.png/v1/fill/w_940,h_788,al_c,q_90,enc_avif,quality_auto/1e97e3_a970aa90bd0b4a91a4c4241afc6dc41c~mv2.png)
![[COVID-19] 11.17.2020 COUNT](https://static.wixstatic.com/media/1e97e3_d7ce00e1316f4f9bb8b3d2556f69e6bf~mv2.png/v1/fill/w_733,h_615,al_c,q_90,enc_avif,quality_auto/1e97e3_d7ce00e1316f4f9bb8b3d2556f69e6bf~mv2.png)
.png)
VITAL VOICE
bottom of page
PFIZER AND BIONTECH CONCLUDE PHASE 3 STUDY OF COVID-19 VACCINE CANDIDATE, MEETING ALL PRIMARY EFFICACY ENDPOINTS
Source: https://bit.ly/3pEQGCJ
Comments